๐ˆ๐ง๐ญ๐ซ๐š๐ญ๐ก๐ž๐œ๐š๐ฅ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ, ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ, ๐๐ž๐ฐ๐ฌ, ๐“๐ซ๐ž๐ง๐๐ฌ, ๐’๐ก๐š๐ซ๐ž - 2024 ๐ญ๐จ 2032

๐•๐ข๐ž๐ฐ ๐ฆ๐จ๐ซ๐ž: https://www.reportsandinsights.....com/report/intrathe

Business

The intrathecal therapy market was valued at US$ 1.2 Billion in 2023 and is expected to register a CAGR of 7.4% over the forecast period and reach US$ 2.3 Bn in 2032.